Inflammatory bowel disease: where we are now?

Lau, Esther and Steadman, Kathryn (2012) Inflammatory bowel disease: where we are now?. Australian Pharmacist, 31 7: 572-576.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
Author Lau, Esther
Steadman, Kathryn
Title Inflammatory bowel disease: where we are now?
Journal name Australian Pharmacist   Check publisher's open access policy
ISSN 0728-4632
Publication date 2012-07
Sub-type Article (original research)
Volume 31
Issue 7
Start page 572
End page 576
Total pages 5
Place of publication Curtin, ACT, Australia
Publisher Pharmaceutical Society of Australia
Collection year 2013
Language eng
Formatted abstract
Inflammatory bowel disease (IBD) describes a group of chronic relapsing inflammatory conditions which affect the gastrointestinal tract (GIT), with the two most common types being Crohn's disease (CD), and ulcerative colitis (UC). These two types of IBD are mainly differentiated by the regions of the GIT affected:

- CD: the inflammation may extend through the length of the intestinal wall, and the inflammation may affect any region of the GIT. Furthermore, the inflammation is not continuous so regions of inflamed tissues may be intersected by normal and healthy regions.

- UC: the mucosal layer is affected, and inflammation is largely confined to the colon, where it starts from the rectum and extends towards the caecum continuously for a variable distance.
Q-Index Code CX
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Non HERDC
School of Pharmacy Publications
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Tue, 08 Jan 2013, 14:07:03 EST by Charna Kovacevic on behalf of School of Pharmacy